Researcher


My Grants

2024–2028 – UNSW Ideas Grant 

  • Project Title: Personalising neoadjuvant therapy for early-stage, high-risk triple-negative breast cancer 

  • CIA: Jeff Holst | CIB: Kanu Wahi | CIC: Morteza Aghmesheh 

  • Funding: $1,421,151.20 | Application No.: 2037397 

2019–2021 – Cancer Australia Priority-Driven Collaborative Cancer Research Scheme 

  • Title: Implantable drug-eluting device for localised drug delivery in unresectable...view more


My Grants

2024–2028 – UNSW Ideas Grant 

  • Project Title: Personalising neoadjuvant therapy for early-stage, high-risk triple-negative breast cancer 

  • CIA: Jeff Holst | CIB: Kanu Wahi | CIC: Morteza Aghmesheh 

  • Funding: $1,421,151.20 | Application No.: 2037397 

2019–2021 – Cancer Australia Priority-Driven Collaborative Cancer Research Scheme 

  • Title: Implantable drug-eluting device for localised drug delivery in unresectable pancreatic cancer 

  • CIA: Kara Vine | CIB: Simon Moulton | CIC: Morteza Aghmesheh (clinical lead) 

  • Funding: $554,920 | Application No.: 1165978 

2020 – CONCERT ECR Grant 

  • Title: Localised Immunotherapy for Pancreatic Cancer: Targeting CD40 to enhance tumour immunity 

  • CI: Kara Vine | AI: Minoti Apte, Morteza Aghmesheh, Daniel Brungs, Lorraine Chantrill, Desmond Yip 

  • Funding: $100,000 

2019 – Breast Cancer Illawarra Grant 

  • Title: Local immunotherapy delivery via implantable device for triple-negative breast cancer 

  • CIA: Morteza Aghmesheh | CIB: Kara Perrow | CIC: Philip Clingan 

  • Funding: $58,000 

2015 – IHMRI Near-Miss Grant Scheme (NHMRC) 

  • Title: 3D dual-drug-eluting polymeric structures for neoadjuvant pancreatic cancer therapy 

  • CIA: Kara Vine | CIB: Morteza Aghmesheh 

  • Funding: $20,000 

Shape 

Philanthropic & Institutional Grants 

2025 – Donation from a family 

  • Purpose: Research in colorectal cancer at POWH/UNSW 

  • Responsible: Morteza Aghmesheh 

  • Fund: $50,000 

2023 – Illawarra Cancer Carers Grant 

  • Purpose: Equipment for Illawarra & Shoalhaven Cancer Biobank 

  • Applicant: Morteza Aghmesheh 

  • Funding: $56,000 

2017 – IHMRI Seeding Grant 

  • Title: Immune network analysis in HNSCC during chemoradiation 

  • CIA: Morteza Aghmesheh | CIB: Thomas Guy | CIC: Daniel Brungs | CID: Ronald Sluyter 

  • Funding: $25,000 

2017 – Illawarra Cancer Carers Grant 

  • Title: Animal study of implantable drug-eluting device for LAPC 

  • CIA: Morteza Aghmesheh | CIB: Kara Perrow | CIC: Samantha Wade 

  • Funding: $20,000 

2015 – Illawarra Cancer Carers Grant 

  • Title: Circulating Tumour Cells (CTCs) in early and advanced gastro-oesophageal cancers 

  • CIA: Kara Perrow | CIB: Daniel Brungs | CIC: Morteza Aghmesheh 

  • Funding: $20,000 

2014 – Illawarra Cancer Carers Fund 

  • Title: Purchasing a mobile ultrasound for chemotherapy unit at Illawarra cancer care centre 

  • Responsible: Morteza Aghmesheh 

  • Funding: $14,000 


My Qualifications

  • 2024 – Australian Clinical Entrepreneur Program (AUSCEP) (2023–2024) 

  • 2008 – FRACP (Medical Oncology), Sydney, Australia 

  • 2003 – PhD (Cancer Genetics), UNSW & Prince of Wales Hospital, Sydney 

  • Research partly undertaken at the Department of Gynaecological Oncology and Anatomical Pathology, Norwegian Radium Hospital, Oslo, Norway 

  • 1998 – Graduate Diploma in Molecular Genetics, UNSW, Sydney 

  • 1994 – MD, Isfahan University of Medical Sciences, Iran 

View less

ORCID as entered in ROS